Enovis (ENOV) to Release Earnings on Wednesday

Enovis (NYSE:ENOV - Get Free Report) is expected to post its quarterly earnings results before the market opens on Wednesday, February 26th. Analysts expect Enovis to post earnings of $0.92 per share and revenue of $555.14 million for the quarter. Individual that are interested in participating in the company's earnings conference call can do so using this link.

Enovis Stock Performance

Shares of ENOV traded down $0.63 during trading hours on Thursday, hitting $43.92. The company had a trading volume of 536,327 shares, compared to its average volume of 979,022. The company has a quick ratio of 1.12, a current ratio of 2.27 and a debt-to-equity ratio of 0.40. The business has a fifty day moving average of $45.15 and a 200-day moving average of $44.33. Enovis has a 12 month low of $38.27 and a 12 month high of $65.03. The firm has a market cap of $2.50 billion, a price-to-earnings ratio of -20.05 and a beta of 1.94.

Analyst Ratings Changes

Separately, Needham & Company LLC restated a "buy" rating and issued a $65.00 price target on shares of Enovis in a research note on Thursday, November 7th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $64.83.

Enovis Company Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.